drugset / Trial / NCT06456528
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of QL0911 in cancer treatment-induced thrombocytopenia. Thrombocytopenia is a low number of platelets in the blood. Sometimes, thrombocytopenia is a side effect of cancer treatment.
Timeline
- Start
- 2024-10-22
- Primary completion
- 2026-07
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QL0911 | Protein / enzyme biologic | — | — |